{"id":1363,"date":"2016-02-29T15:09:03","date_gmt":"2016-02-29T14:09:03","guid":{"rendered":"https:\/\/ngm-cancer.com\/en\/?page_id=1363"},"modified":"2016-03-07T11:36:06","modified_gmt":"2016-03-07T10:36:06","slug":"new-immunotherapeutic-therapeutic-approaches","status":"publish","type":"page","link":"https:\/\/ngm-cancer.com\/en\/new-immunotherapeutic-therapeutic-approaches\/","title":{"rendered":"New immunotherapeutic therapeutic approaches"},"content":{"rendered":"<p>[et_pb_section admin_label=&#8221;Sektion&#8221; global_module=&#8221;1240&#8243; fullwidth=&#8221;on&#8221; specialty=&#8221;off&#8221; transparent_background=&#8221;off&#8221; allow_player_pause=&#8221;off&#8221; inner_shadow=&#8221;off&#8221; parallax=&#8221;off&#8221; parallax_method=&#8221;off&#8221; padding_mobile=&#8221;off&#8221; make_fullwidth=&#8221;off&#8221; use_custom_width=&#8221;off&#8221; width_unit=&#8221;on&#8221; make_equal=&#8221;off&#8221; use_custom_gutter=&#8221;off&#8221;][et_pb_fullwidth_slider global_parent=&#8221;1240&#8243; admin_label=&#8221;Vollbreiter Slider&#8221; show_arrows=&#8221;on&#8221; show_pagination=&#8221;on&#8221; auto=&#8221;off&#8221; auto_ignore_hover=&#8221;off&#8221; parallax=&#8221;off&#8221; parallax_method=&#8221;off&#8221; remove_inner_shadow=&#8221;off&#8221; background_position=&#8221;default&#8221; background_size=&#8221;default&#8221; hide_content_on_mobile=&#8221;off&#8221; hide_cta_on_mobile=&#8221;off&#8221; show_image_video_mobile=&#8221;off&#8221; custom_button=&#8221;off&#8221; button_border_radius=&#8221;0&#8243; button_letter_spacing=&#8221;0&#8243; button_use_icon=&#8221;default&#8221; button_icon_placement=&#8221;right&#8221; button_on_hover=&#8221;on&#8221; button_border_radius_hover=&#8221;0&#8243; button_letter_spacing_hover=&#8221;0&#8243; custom_css_main_element=&#8221;height:350px;&#8221; custom_css_slide_description=&#8221;height:350px;&#8221;]<\/p>\n<p>[et_pb_slide background_image=&#8221;https:\/\/ngm-cancer.com\/wp-content\/uploads\/2016\/02\/291_1920x400_iStock_000069171885_Full.jpg&#8221; background_position=&#8221;default&#8221; background_size=&#8221;default&#8221; background_color=&#8221;#ffffff&#8221; use_bg_overlay=&#8221;off&#8221; use_text_overlay=&#8221;off&#8221; alignment=&#8221;center&#8221; background_layout=&#8221;dark&#8221; allow_player_pause=&#8221;off&#8221; text_border_radius=&#8221;3&#8243; header_font_select=&#8221;default&#8221; header_font=&#8221;||||&#8221; body_font_select=&#8221;default&#8221; body_font=&#8221;||||&#8221; custom_button=&#8221;off&#8221; button_font_select=&#8221;default&#8221; button_font=&#8221;||||&#8221; button_use_icon=&#8221;default&#8221; button_icon_placement=&#8221;right&#8221; button_on_hover=&#8221;on&#8221;] [\/et_pb_slide][et_pb_slide background_image=&#8221;https:\/\/ngm-cancer.com\/wp-content\/uploads\/2016\/02\/291_1920x400_iStock_000015723751_Double.jpg&#8221; background_position=&#8221;default&#8221; background_size=&#8221;default&#8221; background_color=&#8221;#ffffff&#8221; use_bg_overlay=&#8221;off&#8221; use_text_overlay=&#8221;off&#8221; alignment=&#8221;center&#8221; background_layout=&#8221;dark&#8221; allow_player_pause=&#8221;off&#8221; text_border_radius=&#8221;3&#8243; header_font_select=&#8221;default&#8221; header_font=&#8221;||||&#8221; body_font_select=&#8221;default&#8221; body_font=&#8221;||||&#8221; custom_button=&#8221;off&#8221; button_font_select=&#8221;default&#8221; button_font=&#8221;||||&#8221; button_use_icon=&#8221;default&#8221; button_icon_placement=&#8221;right&#8221; button_on_hover=&#8221;on&#8221;] [\/et_pb_slide][et_pb_slide background_image=&#8221;https:\/\/ngm-cancer.com\/wp-content\/uploads\/2016\/02\/291_1920x400_iStock_000019005992_XXXLarge.jpg&#8221; background_position=&#8221;default&#8221; background_size=&#8221;default&#8221; background_color=&#8221;#ffffff&#8221; use_bg_overlay=&#8221;off&#8221; use_text_overlay=&#8221;off&#8221; alignment=&#8221;center&#8221; background_layout=&#8221;dark&#8221; allow_player_pause=&#8221;off&#8221; text_border_radius=&#8221;3&#8243; header_font_select=&#8221;default&#8221; header_font=&#8221;||||&#8221; body_font_select=&#8221;default&#8221; body_font=&#8221;||||&#8221; custom_button=&#8221;off&#8221; button_font_select=&#8221;default&#8221; button_font=&#8221;||||&#8221; button_use_icon=&#8221;default&#8221; button_icon_placement=&#8221;right&#8221; button_on_hover=&#8221;on&#8221;] [\/et_pb_slide]<\/p>\n<p>[\/et_pb_fullwidth_slider][\/et_pb_section][et_pb_section admin_label=&#8221;Sektion&#8221; fullwidth=&#8221;off&#8221; specialty=&#8221;on&#8221;][et_pb_column type=&#8221;3_4&#8243; specialty_columns=&#8221;3&#8243;][et_pb_row_inner admin_label=&#8221;Zeile&#8221;][et_pb_column_inner type=&#8221;4_4&#8243; saved_specialty_column_type=&#8221;3_4&#8243;][et_pb_post_title admin_label=&#8221;Posttitel&#8221; title=&#8221;on&#8221; meta=&#8221;off&#8221; author=&#8221;on&#8221; date=&#8221;on&#8221; categories=&#8221;on&#8221; comments=&#8221;on&#8221; featured_image=&#8221;off&#8221; featured_placement=&#8221;below&#8221; parallax_effect=&#8221;on&#8221; parallax_method=&#8221;on&#8221; text_orientation=&#8221;left&#8221; text_color=&#8221;dark&#8221; text_background=&#8221;off&#8221; text_bg_color=&#8221;rgba(255,255,255,0.9)&#8221; module_bg_color=&#8221;rgba(255,255,255,0)&#8221; title_all_caps=&#8221;off&#8221; use_border_color=&#8221;off&#8221; border_color=&#8221;#ffffff&#8221; border_style=&#8221;solid&#8221;]<\/p>\n<p>[\/et_pb_post_title][et_pb_text admin_label=&#8221;Text&#8221; background_layout=&#8221;light&#8221; text_orientation=&#8221;left&#8221; use_border_color=&#8221;off&#8221; border_color=&#8221;#ffffff&#8221; border_style=&#8221;solid&#8221;]<\/p>\n<p><div class='two_third'>\n\t\t\t\t\tFor a long time all attempts to use the body&#8217;s own immune response against tumor cells for an effective lung cancer therapy had been without success. The increasing comprehension of the molecular control of the immune system has recently lead to the development of new drugs, the so-called immune checkpoint inhibitors (also called anti-PD1, anti PDL1 antibody), which have a surprisingly good efficacy in various forms of lung cancer. The effectiveness is due to an activation of the body&#8217;s own T cells (T-lymphocytes) against the tumor cells.\n\t\t\t\t<\/div><br \/>\n<div class='one_third et_column_last'>\n\t\t\t\t\t<img loading=\"lazy\" class=\"alignnone size-full wp-image-1362\" src=\"https:\/\/ngm-cancer.com\/wp-content\/uploads\/2015\/12\/csm_immuntherapie_Fotolia_63291602_S_f4110ddd2a.jpg\" alt=\"immuntherapie\" width=\"300\" height=\"199\" \/>\n\t\t\t\t<\/div><div class='clear'><\/div><\/p>\n<p>[\/et_pb_text][et_pb_text admin_label=&#8221;Text&#8221; background_layout=&#8221;light&#8221; text_orientation=&#8221;left&#8221; use_border_color=&#8221;off&#8221; border_color=&#8221;#ffffff&#8221; border_style=&#8221;solid&#8221;]<\/p>\n<p>The first PD1 antibody has already been approved after failure of chemotherapy in squamous cell carcinoma of the lung. In addition to an improved tolerability, the survival of patients with this therapy is better than with chemotherapy.<\/p>\n<p>Also in adenocarcinoma of the lung the approval of such drugs can be expected soon. In trials, they are also tested in small cell lung cancer.<\/p>\n<p>[\/et_pb_text][\/et_pb_column_inner][\/et_pb_row_inner][et_pb_row_inner admin_label=&#8221;Zeile&#8221;][et_pb_column_inner type=&#8221;4_4&#8243; saved_specialty_column_type=&#8221;3_4&#8243;][et_pb_text admin_label=&#8221;Last Update&#8221; global_module=&#8221;1340&#8243; saved_tabs=&#8221;all&#8221; background_layout=&#8221;light&#8221; text_orientation=&#8221;left&#8221; use_border_color=&#8221;off&#8221; border_color=&#8221;#ffffff&#8221; border_style=&#8221;solid&#8221; module_class=&#8221;content-update&#8221;]<\/p>\n<p><em>Last update: <span class=\"last-modified-timestamp\">07. March 2016 , 11:36<\/span><\/em><\/p>\n<p>[\/et_pb_text][\/et_pb_column_inner][\/et_pb_row_inner][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243;][et_pb_sidebar admin_label=&#8221;Seitenleiste&#8221; orientation=&#8221;right&#8221; area=&#8221;et_pb_widget_area_6&#8243; background_layout=&#8221;light&#8221; remove_border=&#8221;off&#8221;]<\/p>\n<p>[\/et_pb_sidebar][\/et_pb_column][\/et_pb_section][et_pb_section admin_label=&#8221;section&#8221; global_module=&#8221;1336&#8243; fullwidth=&#8221;off&#8221; transparent_background=&#8221;off&#8221; background_color=&#8221;#eeeeee&#8221; allow_player_pause=&#8221;off&#8221; inner_shadow=&#8221;off&#8221; parallax=&#8221;on&#8221; parallax_method=&#8221;on&#8221; padding_mobile=&#8221;off&#8221; make_fullwidth=&#8221;off&#8221; use_custom_width=&#8221;off&#8221; width_unit=&#8221;on&#8221; make_equal=&#8221;off&#8221; use_custom_gutter=&#8221;off&#8221; gutter_width=&#8221;3&#8243; background_image=&#8221;https:\/\/ngm-cancer.com\/wp-content\/uploads\/2015\/12\/291_ngm_BG-t5.png&#8221;][et_pb_row global_parent=&#8221;1336&#8243; admin_label=&#8221;row&#8221; make_fullwidth=&#8221;off&#8221; use_custom_width=&#8221;off&#8221; width_unit=&#8221;on&#8221; use_custom_gutter=&#8221;off&#8221; gutter_width=&#8221;3&#8243; padding_mobile=&#8221;off&#8221; allow_player_pause=&#8221;off&#8221; parallax=&#8221;off&#8221; parallax_method=&#8221;on&#8221; make_equal=&#8221;on&#8221; parallax_1=&#8221;off&#8221; parallax_method_1=&#8221;off&#8221; background_color_1=&#8221;#ffffff&#8221; padding_top_1=&#8221;50px&#8221; padding_right_1=&#8221;32px&#8221; padding_bottom_1=&#8221;50px&#8221; padding_left_1=&#8221;32px&#8221; parallax_2=&#8221;off&#8221; parallax_method_2=&#8221;off&#8221; background_color_2=&#8221;#ffffff&#8221; padding_top_2=&#8221;50px&#8221; padding_right_2=&#8221;32px&#8221; padding_bottom_2=&#8221;50px&#8221; padding_left_2=&#8221;32px&#8221; parallax_3=&#8221;off&#8221; parallax_method_3=&#8221;off&#8221; background_color_3=&#8221;#ffffff&#8221; padding_top_3=&#8221;50px&#8221; padding_right_3=&#8221;32px&#8221; padding_bottom_3=&#8221;50px&#8221; padding_left_3=&#8221;32px&#8221; column_padding_mobile=&#8221;on&#8221; module_id=&#8221;pseudofooter-row&#8221;][et_pb_column type=&#8221;1_3&#8243;][et_pb_blurb global_parent=&#8221;1336&#8243; admin_label=&#8221;Molekulare Diagnostik&#8221; title=&#8221;Molecular diagnostics&#8221; url_new_window=&#8221;off&#8221; animation=&#8221;off&#8221; background_layout=&#8221;light&#8221; text_orientation=&#8221;center&#8221; icon_placement=&#8221;top&#8221; font_icon=&#8221;%%103%%&#8221; use_icon=&#8221;on&#8221; use_circle=&#8221;off&#8221; use_circle_border=&#8221;off&#8221; icon_color=&#8221;#3b78aa&#8221; circle_color=&#8221;#81d742&#8243; circle_border_color=&#8221;#2caaca&#8221; url=&#8221;\/?p=74\/&#8221; use_icon_font_size=&#8221;off&#8221; use_border_color=&#8221;off&#8221; border_color=&#8221;#ffffff&#8221; border_style=&#8221;solid&#8221; header_line_height=&#8221;1.5em&#8221;]<\/p>\n<p>As the first group in Europe, the Network Genomic Medicine has offered a comprehensive analysis of tumor material since 2012. By means of a multiplex-test in combination with highly sensitive deep sequencing even rare gene mutations in the smallest tissue samples are detected reliably<\/p>\n<p>[\/et_pb_blurb][et_pb_divider global_parent=&#8221;1336&#8243; admin_label=&#8221;Teiler&#8221; color=&#8221;#ffffff&#8221; show_divider=&#8221;off&#8221; divider_style=&#8221;solid&#8221; divider_position=&#8221;top&#8221; hide_on_mobile=&#8221;on&#8221; height=&#8221;2&#8243;]<\/p>\n<p>[\/et_pb_divider][et_pb_cta global_parent=&#8221;1336&#8243; admin_label=&#8221;Diagnostik&#8221; button_url=&#8221;https:\/\/ngm-cancer.com\/en\/diagnostics\/&#8221; url_new_window=&#8221;off&#8221; button_text=&#8221;Diagnostics&#8221; use_background_color=&#8221;off&#8221; background_color=&#8221;#4d9acf&#8221; background_layout=&#8221;light&#8221; text_orientation=&#8221;center&#8221; use_border_color=&#8221;off&#8221; border_color=&#8221;#ffffff&#8221; border_style=&#8221;solid&#8221; custom_button=&#8221;off&#8221; button_text_size=&#8221;16&#8243; button_border_radius=&#8221;0&#8243; button_letter_spacing=&#8221;0&#8243; button_use_icon=&#8221;default&#8221; button_icon_placement=&#8221;right&#8221; button_on_hover=&#8221;on&#8221; button_border_radius_hover=&#8221;0&#8243; button_letter_spacing_hover=&#8221;0&#8243;]<\/p>\n<p>[\/et_pb_cta][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243;][et_pb_blurb global_parent=&#8221;1336&#8243; admin_label=&#8221;Second opinion&#8221; title=&#8221;Second opinion&#8221; url_new_window=&#8221;off&#8221; animation=&#8221;off&#8221; background_layout=&#8221;light&#8221; text_orientation=&#8221;center&#8221; icon_placement=&#8221;top&#8221; font_icon=&#8221;%%86%%&#8221; use_icon=&#8221;on&#8221; use_circle=&#8221;off&#8221; use_circle_border=&#8221;off&#8221; icon_color=&#8221;#3b78aa&#8221; circle_color=&#8221;#999999&#8243; circle_border_color=&#8221;#2caaca&#8221; url=&#8221;\/?p=76\/&#8221; use_icon_font_size=&#8221;off&#8221; use_border_color=&#8221;off&#8221; border_color=&#8221;#ffffff&#8221; border_style=&#8221;solid&#8221; header_line_height=&#8221;1.5em&#8221;]<\/p>\n<p>Do you have questions about your disease or your current therapy? Or maybe you would like to know if for you a personalized treatment approach or immunotherapy might be considered. Please feel free to contact us!<\/p>\n<p>[\/et_pb_blurb][et_pb_divider global_parent=&#8221;1336&#8243; admin_label=&#8221;Teiler&#8221; color=&#8221;#ffffff&#8221; show_divider=&#8221;off&#8221; height=&#8221;53&#8243; divider_style=&#8221;solid&#8221; divider_position=&#8221;top&#8221; hide_on_mobile=&#8221;on&#8221;]<\/p>\n<p>[\/et_pb_divider][et_pb_cta global_parent=&#8221;1336&#8243; admin_label=&#8221;Zweitmeinung&#8221; button_url=&#8221;https:\/\/ngm-cancer.com\/en\/second-opinion-service\/&#8221; url_new_window=&#8221;off&#8221; button_text=&#8221;Second Opinion&#8221; use_background_color=&#8221;off&#8221; background_color=&#8221;#4d9acf&#8221; background_layout=&#8221;light&#8221; text_orientation=&#8221;center&#8221; use_border_color=&#8221;off&#8221; border_color=&#8221;#ffffff&#8221; border_style=&#8221;solid&#8221; custom_button=&#8221;off&#8221; button_text_size=&#8221;16&#8243; button_border_radius=&#8221;0&#8243; button_letter_spacing=&#8221;0&#8243; button_use_icon=&#8221;default&#8221; button_icon_placement=&#8221;right&#8221; button_on_hover=&#8221;on&#8221; button_border_radius_hover=&#8221;0&#8243; button_letter_spacing_hover=&#8221;0&#8243;]<\/p>\n<p>[\/et_pb_cta][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243;][et_pb_blurb global_parent=&#8221;1336&#8243; admin_label=&#8221;Clinical trials&#8221; title=&#8221;Clinical trials&#8221; url_new_window=&#8221;off&#8221; animation=&#8221;off&#8221; background_layout=&#8221;light&#8221; text_orientation=&#8221;center&#8221; icon_placement=&#8221;top&#8221; font_icon=&#8221;%%77%%&#8221; use_icon=&#8221;on&#8221; use_circle=&#8221;off&#8221; use_circle_border=&#8221;off&#8221; icon_color=&#8221;#3b78aa&#8221; circle_color=&#8221;#81d742&#8243; circle_border_color=&#8221;#2caaca&#8221; url=&#8221;\/?p=76\/&#8221; use_icon_font_size=&#8221;off&#8221; use_border_color=&#8221;off&#8221; border_color=&#8221;#ffffff&#8221; border_style=&#8221;solid&#8221; header_line_height=&#8221;1.5em&#8221;]<\/p>\n<p>At the Network Genomic Medicine we try to offer an appropriate clinical trial testing a new drug to all our patients who have a detected mutation, for which there has no drug been approved for treatment yet. For that we work closely together with the Lung Cancer Group Cologne.<\/p>\n<p>[\/et_pb_blurb][et_pb_divider global_parent=&#8221;1336&#8243; admin_label=&#8221;Teiler&#8221; color=&#8221;#ffffff&#8221; show_divider=&#8221;off&#8221; height=&#8221;2&#8243; divider_style=&#8221;solid&#8221; divider_position=&#8221;top&#8221; hide_on_mobile=&#8221;on&#8221;]<\/p>\n<p>[\/et_pb_divider][et_pb_cta global_parent=&#8221;1336&#8243; admin_label=&#8221;Studien&#8221; button_url=&#8221;https:\/\/ngm-cancer.com\/en\/clinical-trials\/&#8221; url_new_window=&#8221;off&#8221; button_text=&#8221;Trials&#8221; use_background_color=&#8221;off&#8221; background_color=&#8221;#4d9acf&#8221; background_layout=&#8221;light&#8221; text_orientation=&#8221;center&#8221; use_border_color=&#8221;off&#8221; border_color=&#8221;#ffffff&#8221; border_style=&#8221;solid&#8221; custom_button=&#8221;off&#8221; button_text_size=&#8221;16&#8243; button_border_radius=&#8221;0&#8243; button_letter_spacing=&#8221;0&#8243; button_use_icon=&#8221;default&#8221; button_icon_placement=&#8221;right&#8221; button_on_hover=&#8221;on&#8221; button_border_radius_hover=&#8221;0&#8243; button_letter_spacing_hover=&#8221;0&#8243;]<\/p>\n<p>[\/et_pb_cta][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p><div class='two_third'>\n\t\t\t\t\t\n\t\t\t\t<\/div>For a long time all attempts to use the body&#8217;s own immune response against tumor cells for an effective lung cancer therapy had been without success. The increasing comprehension of the molecular control of the immune system has recently lead to the development of new drugs, the so-called immune checkpoint inhibitors (also called anti-PD1, anti [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":0,"parent":0,"menu_order":18,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"[et_pb_section admin_label=\"Sektion\" global_module=\"1240\" fullwidth=\"on\" specialty=\"off\" transparent_background=\"off\" allow_player_pause=\"off\" inner_shadow=\"off\" parallax=\"off\" parallax_method=\"off\" padding_mobile=\"off\" make_fullwidth=\"off\" use_custom_width=\"off\" width_unit=\"on\" make_equal=\"off\" use_custom_gutter=\"off\"][et_pb_fullwidth_slider global_parent=\"1240\" admin_label=\"Vollbreiter Slider\" show_arrows=\"on\" show_pagination=\"on\" auto=\"off\" auto_ignore_hover=\"off\" parallax=\"off\" parallax_method=\"off\" remove_inner_shadow=\"off\" background_position=\"default\" background_size=\"default\" hide_content_on_mobile=\"off\" hide_cta_on_mobile=\"off\" show_image_video_mobile=\"off\" custom_button=\"off\" button_border_radius=\"0\" button_letter_spacing=\"0\" button_use_icon=\"default\" button_icon_placement=\"right\" button_on_hover=\"on\" button_border_radius_hover=\"0\" button_letter_spacing_hover=\"0\" custom_css_main_element=\"height:350px;\" custom_css_slide_description=\"height:350px;\"]\r\n\r\n[et_pb_slide background_image=\"https:\/\/ngm-cancer.com\/wp-content\/uploads\/2016\/02\/stock-photo-69171885-dna-molecules.jpg\" background_position=\"default\" background_size=\"default\" background_color=\"#ffffff\" use_bg_overlay=\"off\" use_text_overlay=\"off\" alignment=\"center\" background_layout=\"dark\" allow_player_pause=\"off\" text_border_radius=\"3\" header_font_select=\"default\" header_font=\"||||\" body_font_select=\"default\" body_font=\"||||\" custom_button=\"off\" button_font_select=\"default\" button_font=\"||||\" button_use_icon=\"default\" button_icon_placement=\"right\" button_on_hover=\"on\"]\r\n\r\n\r\n\r\n[\/et_pb_slide][et_pb_slide background_image=\"https:\/\/ngm-cancer.com\/wp-content\/uploads\/2016\/02\/stock-photo-15723751-lung-cancer.jpg\" background_position=\"default\" background_size=\"default\" background_color=\"#ffffff\" use_bg_overlay=\"off\" use_text_overlay=\"off\" alignment=\"center\" background_layout=\"dark\" allow_player_pause=\"off\" text_border_radius=\"3\" header_font_select=\"default\" header_font=\"||||\" body_font_select=\"default\" body_font=\"||||\" custom_button=\"off\" button_font_select=\"default\" button_font=\"||||\" button_use_icon=\"default\" button_icon_placement=\"right\" button_on_hover=\"on\"]\r\n\r\n\r\n\r\n[\/et_pb_slide][et_pb_slide background_image=\"https:\/\/ngm-cancer.com\/wp-content\/uploads\/2016\/02\/stock-photo-19005992-dna.jpg\" background_position=\"default\" background_size=\"default\" background_color=\"#ffffff\" use_bg_overlay=\"off\" use_text_overlay=\"off\" alignment=\"center\" background_layout=\"dark\" allow_player_pause=\"off\" text_border_radius=\"3\" header_font_select=\"default\" header_font=\"||||\" body_font_select=\"default\" body_font=\"||||\" custom_button=\"off\" button_font_select=\"default\" button_font=\"||||\" button_use_icon=\"default\" button_icon_placement=\"right\" button_on_hover=\"on\"]\r\n\r\n\r\n\r\n[\/et_pb_slide]\r\n\r\n[\/et_pb_fullwidth_slider][\/et_pb_section][et_pb_section admin_label=\"Sektion\" fullwidth=\"off\" specialty=\"on\"][et_pb_column type=\"3_4\" specialty_columns=\"3\"][et_pb_row_inner admin_label=\"Zeile\"][et_pb_column_inner type=\"4_4\" saved_specialty_column_type=\"3_4\"][et_pb_post_title admin_label=\"Posttitel\" title=\"on\" meta=\"off\" author=\"on\" date=\"on\" categories=\"on\" comments=\"on\" featured_image=\"off\" featured_placement=\"below\" parallax_effect=\"on\" parallax_method=\"on\" text_orientation=\"left\" text_color=\"dark\" text_background=\"off\" text_bg_color=\"rgba(255,255,255,0.9)\" module_bg_color=\"rgba(255,255,255,0)\" title_all_caps=\"off\" use_border_color=\"off\" border_color=\"#ffffff\" border_style=\"solid\"]\r\n\r\n\r\n\r\n[\/et_pb_post_title][et_pb_text admin_label=\"Text\" background_layout=\"light\" text_orientation=\"left\" use_border_color=\"off\" border_color=\"#ffffff\" border_style=\"solid\"]\r\n\r\n[two_third]Lange Zeit waren s\u00e4mtliche Versuche, die k\u00f6rpereigene Immunantwort gegen Tumorzellen f\u00fcr eine wirksame Lungenkrebstherapie zu nutzen, erfolglos. Das zunehmende molekulare Verst\u00e4ndnis der Steuerung des Immunsystems hat in j\u00fcngster Zeit zur Entwicklung von neuen Medikamenten, sogenannten Immuncheckpoint-Inhibitoren (auch anti-PD1-, anti PDL1-Antik\u00f6rper genannt), mit einer \u00fcberraschend guten Wirksamkeit bei verschiedenen Formen von Lungenkrebs gef\u00fchrt. Die Wirksamkeit beruht auf einer Aktivierung der k\u00f6rpereigenen T-Zellen (T-Lymphozyten) gegen die Tumorzellen.[\/two_third]\r\n<a href=\"https:\/\/ngm-cancer.com\/wp-content\/uploads\/2015\/12\/csm_immuntherapie_Fotolia_63291602_S_f4110ddd2a.jpg\" rel=\"attachment wp-att-1362\"><img src=\"https:\/\/ngm-cancer.com\/wp-content\/uploads\/2015\/12\/csm_immuntherapie_Fotolia_63291602_S_f4110ddd2a.jpg\" alt=\"immuntherapie\" width=\"300\" height=\"199\" class=\"alignnone size-full wp-image-1362\" \/><\/a>\r\n\r\n[\/et_pb_text][et_pb_text admin_label=\"Text\" background_layout=\"light\" text_orientation=\"left\" use_border_color=\"off\" border_color=\"#ffffff\" border_style=\"solid\"]\r\n\r\nDer erste PD1-Antik\u00f6rper ist bereits beim Plattenepithelkarzinom der Lunge nach Versagen einer Chemotherapie zugelassen. Bei besserer Vertr\u00e4glichkeit ist das \u00dcberleben der Patienten mit dieser Therapie besser als mit Chemotherapie.\r\n\r\nAuch beim Adenokarzinom der Lunge ist in K\u00fcrze mit der Zulassung solcher Medikamente zu rechnen. In Studien werden sie auch beim kleinzelligen Bronchialkarzinom erprobt.\r\n\r\n[\/et_pb_text][\/et_pb_column_inner][\/et_pb_row_inner][et_pb_row_inner admin_label=\"Zeile\"][et_pb_column_inner type=\"4_4\" saved_specialty_column_type=\"3_4\"][et_pb_text admin_label=\"Letzte \u00c4nderung\" global_module=\"1196\" saved_tabs=\"all\" background_layout=\"light\" text_orientation=\"left\" use_border_color=\"off\" border_color=\"#ffffff\" border_style=\"solid\" module_class=\"content-update\"]\r\n\r\n<em>Letzte \u00c4nderung: [last-modified datef='d. F Y' sep=',']<\/em>\r\n\r\n[\/et_pb_text][\/et_pb_column_inner][\/et_pb_row_inner][\/et_pb_column][et_pb_column type=\"1_4\"][et_pb_sidebar admin_label=\"Seitenleiste\" orientation=\"right\" area=\"et_pb_widget_area_6\" background_layout=\"light\" remove_border=\"off\"]\r\n\r\n\r\n\r\n[\/et_pb_sidebar][\/et_pb_column][\/et_pb_section][et_pb_section admin_label=\"section\" global_module=\"309\" fullwidth=\"off\" transparent_background=\"off\" background_color=\"#eeeeee\" allow_player_pause=\"off\" inner_shadow=\"off\" parallax=\"on\" parallax_method=\"on\" padding_mobile=\"off\" make_fullwidth=\"off\" use_custom_width=\"off\" width_unit=\"on\" make_equal=\"off\" use_custom_gutter=\"off\" gutter_width=\"3\" background_image=\"https:\/\/ngm-cancer.com\/wp-content\/uploads\/2015\/12\/291_ngm_BG-t5.png\"][et_pb_row global_parent=\"309\" admin_label=\"row\" make_fullwidth=\"off\" use_custom_width=\"off\" width_unit=\"on\" use_custom_gutter=\"off\" gutter_width=\"3\" padding_mobile=\"off\" allow_player_pause=\"off\" parallax=\"off\" parallax_method=\"on\" make_equal=\"on\" parallax_1=\"off\" parallax_method_1=\"off\" background_color_1=\"#ffffff\" padding_top_1=\"50px\" padding_right_1=\"32px\" padding_bottom_1=\"50px\" padding_left_1=\"32px\" parallax_2=\"off\" parallax_method_2=\"off\" background_color_2=\"#ffffff\" padding_top_2=\"50px\" padding_right_2=\"32px\" padding_bottom_2=\"50px\" padding_left_2=\"32px\" parallax_3=\"off\" parallax_method_3=\"off\" background_color_3=\"#ffffff\" padding_top_3=\"50px\" padding_right_3=\"32px\" padding_bottom_3=\"50px\" padding_left_3=\"32px\" column_padding_mobile=\"on\" module_id=\"pseudofooter-row\"][et_pb_column type=\"1_3\"][et_pb_blurb global_parent=\"309\" admin_label=\"Molekulare Diagnostik\" title=\"Molekulare Diagnostik\" url_new_window=\"off\" animation=\"off\" background_layout=\"light\" text_orientation=\"center\" icon_placement=\"top\" font_icon=\"%%103%%\" use_icon=\"on\" use_circle=\"off\" use_circle_border=\"off\" icon_color=\"#3b78aa\" circle_color=\"#81d742\" circle_border_color=\"#2caaca\" url=\"\/?p=74\/\" use_icon_font_size=\"off\" header_font_size=\"18\" body_font_size=\"14\" use_border_color=\"off\" border_color=\"#ffffff\" border_style=\"solid\" header_line_height=\"1.5em\"]\r\n\r\n<p>Das Netzwerk Genomische Medizin bietet eine umfassende molekulare Analyse von Tumorproben an. Mittels eines Next Generation Sequencing basierten Multiplex-Verfahrens werden s\u00e4mtliche therapierelevanten genomischen Ver\u00e4nderungen auch in kleinsten Gewebeproben zuverl\u00e4ssig detektiert.<\/p>\r\n\r\n[\/et_pb_blurb][et_pb_divider global_parent=\"309\" admin_label=\"Teiler\" color=\"#ffffff\" show_divider=\"off\" divider_style=\"solid\" divider_position=\"top\" divider_weight=\"1\" hide_on_mobile=\"on\" height=\"2\"]\r\n\r\n\r\n\r\n[\/et_pb_divider][et_pb_cta global_parent=\"309\" admin_label=\"Diagnostik\" button_url=\"\/molekularpathologie\/diagnostik\/\" url_new_window=\"off\" button_text=\"Diagnostik\" use_background_color=\"off\" background_color=\"#4d9acf\" background_layout=\"light\" text_orientation=\"center\" use_border_color=\"off\" border_color=\"#ffffff\" border_style=\"solid\" custom_button=\"off\" button_text_size=\"16\" button_border_radius=\"0\" button_letter_spacing=\"0\" button_use_icon=\"default\" button_icon_placement=\"right\" button_on_hover=\"on\" button_border_radius_hover=\"0\" button_letter_spacing_hover=\"0\"]\r\n\r\n\r\n\r\n[\/et_pb_cta][\/et_pb_column][et_pb_column type=\"1_3\"][et_pb_blurb global_parent=\"309\" admin_label=\"Zweitmeinung\" title=\"Zweitmeinung\" url_new_window=\"off\" animation=\"off\" background_layout=\"light\" text_orientation=\"center\" icon_placement=\"top\" font_icon=\"%%86%%\" use_icon=\"on\" use_circle=\"off\" use_circle_border=\"off\" icon_color=\"#3b78aa\" circle_color=\"#999999\" circle_border_color=\"#2caaca\" url=\"\/?p=76\/\" use_icon_font_size=\"off\" header_font_size=\"18\" body_font_size=\"14\" use_border_color=\"off\" border_color=\"#ffffff\" border_style=\"solid\" header_line_height=\"1.5em\"]\r\n\r\n<p>Haben Sie Fragen zu Ihrer Erkrankung, Ihrer bestehenden Therapie oder vielleicht m\u00f6chten Sie auch wissen, ob f\u00fcr Sie ein personalisierter Therapieansatz oder eine Immuntherapie in Frage kommt?<\/p><p>Kontaktieren Sie uns!<\/p>\r\n\r\n[\/et_pb_blurb][et_pb_divider global_parent=\"309\" admin_label=\"Teiler\" color=\"#ffffff\" show_divider=\"off\" height=\"32\" divider_style=\"solid\" divider_position=\"top\" divider_weight=\"1\" hide_on_mobile=\"on\"]\r\n\r\n\r\n\r\n[\/et_pb_divider][et_pb_cta global_parent=\"309\" admin_label=\"Zweitmeinung\" button_url=\"\/?p=76\/\" url_new_window=\"off\" button_text=\"Zweitmeinung\" use_background_color=\"off\" background_color=\"#4d9acf\" background_layout=\"light\" text_orientation=\"center\" header_font_size=\"26\" body_font_size=\"14\" use_border_color=\"off\" border_color=\"#ffffff\" border_style=\"solid\" custom_button=\"off\" button_text_size=\"16\" button_border_width=\"2\" button_border_radius=\"0\" button_letter_spacing=\"0\" button_use_icon=\"default\" button_icon_placement=\"right\" button_on_hover=\"on\" button_border_radius_hover=\"0\" button_letter_spacing_hover=\"0\"]\r\n\r\n\r\n\r\n[\/et_pb_cta][\/et_pb_column][et_pb_column type=\"1_3\"][et_pb_blurb global_parent=\"309\" admin_label=\"Klinische Studien\" title=\"Klinische Studien\" url_new_window=\"off\" animation=\"off\" background_layout=\"light\" text_orientation=\"center\" icon_placement=\"top\" font_icon=\"%%77%%\" use_icon=\"on\" use_circle=\"off\" use_circle_border=\"off\" icon_color=\"#3b78aa\" circle_color=\"#81d742\" circle_border_color=\"#2caaca\" url=\"\/?p=76\/\" use_icon_font_size=\"off\" header_font_size=\"18\" body_font_size=\"14\" use_border_color=\"off\" border_color=\"#ffffff\" border_style=\"solid\" header_line_height=\"1.5em\"]\r\n\r\n<p>Innerhalb des Netzwerks Genomische Medizin wollen wir allen Patienten mit einer Mutation, f\u00fcr die es noch kein zugelassenes Medikament gibt, eine klinische Studie anbieten.<\/p><p>Informieren Sie sich hier, welche aktuellen Studien es gibt.<\/p>\r\n\r\n[\/et_pb_blurb][et_pb_divider global_parent=\"309\" admin_label=\"Teiler\" color=\"#ffffff\" show_divider=\"off\" height=\"32\" divider_style=\"solid\" divider_position=\"top\" divider_weight=\"1\" hide_on_mobile=\"on\"]\r\n\r\n\r\n\r\n[\/et_pb_divider][et_pb_cta global_parent=\"309\" admin_label=\"Studien\" button_url=\"\/?p=78\/\" url_new_window=\"off\" button_text=\"Studien\" use_background_color=\"off\" background_color=\"#4d9acf\" background_layout=\"light\" text_orientation=\"center\" header_font_size=\"26\" body_font_size=\"14\" use_border_color=\"off\" border_color=\"#ffffff\" border_style=\"solid\" custom_button=\"off\" button_text_size=\"16\" button_border_width=\"2\" button_border_radius=\"0\" button_letter_spacing=\"0\" button_use_icon=\"default\" button_icon_placement=\"right\" button_on_hover=\"on\" button_border_radius_hover=\"0\" button_letter_spacing_hover=\"0\"]\r\n\r\n\r\n\r\n[\/et_pb_cta][\/et_pb_column][\/et_pb_row][\/et_pb_section]","_et_gb_content_width":""},"kontext":[],"_links":{"self":[{"href":"https:\/\/ngm-cancer.com\/en\/wp-json\/wp\/v2\/pages\/1363"}],"collection":[{"href":"https:\/\/ngm-cancer.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ngm-cancer.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ngm-cancer.com\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/ngm-cancer.com\/en\/wp-json\/wp\/v2\/comments?post=1363"}],"version-history":[{"count":1,"href":"https:\/\/ngm-cancer.com\/en\/wp-json\/wp\/v2\/pages\/1363\/revisions"}],"predecessor-version":[{"id":1991,"href":"https:\/\/ngm-cancer.com\/en\/wp-json\/wp\/v2\/pages\/1363\/revisions\/1991"}],"wp:attachment":[{"href":"https:\/\/ngm-cancer.com\/en\/wp-json\/wp\/v2\/media?parent=1363"}],"wp:term":[{"taxonomy":"kontext","embeddable":true,"href":"https:\/\/ngm-cancer.com\/en\/wp-json\/wp\/v2\/kontext?post=1363"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}